Delayed
Japan Exchange
06:40:15 13/05/2024 am IST
|
5-day change
|
1st Jan Change
|
1,31,600
JPY
|
+0.08%
|
|
-1.64%
|
-5.87%
|
Fiscal Period: Gennaio |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Capitalization
1 |
22,613
|
42,732
|
41,830
|
46,828
|
58,239
|
47,346
|
Enterprise Value (EV)
1 |
53,166
|
74,258
|
73,188
|
84,167
|
95,776
|
84,631
|
P/E ratio
|
17.4
x
|
23.3
x
|
23
x
|
21.4
x
|
24.8
x
|
22.4
x
|
Yield
|
-
|
-
|
-
|
-
|
4.27%
|
4.95%
|
Capitalization / Revenue
|
5.63
x
|
10.6
x
|
10.2
x
|
9.88
x
|
11.5
x
|
9.71
x
|
EV / Revenue
|
13.2
x
|
18.4
x
|
17.8
x
|
17.7
x
|
18.9
x
|
17.4
x
|
EV / EBITDA
|
16.2
x
|
24.3
x
|
23.7
x
|
23.1
x
|
24.9
x
|
23.2
x
|
EV / FCF
|
-1.18
x
|
-78.1
x
|
44.4
x
|
-3.75
x
|
35.1
x
|
34.9
x
|
FCF Yield
|
-84.5%
|
-1.28%
|
2.25%
|
-26.6%
|
2.85%
|
2.87%
|
Price to Book
|
1.09
x
|
1.29
x
|
1.27
x
|
1.21
x
|
1.51
x
|
1.23
x
|
Nbr of stocks (in thousands)
|
193
|
311
|
311
|
357
|
360
|
360
|
Reference price
2 |
1,17,100
|
1,37,400
|
1,34,500
|
1,31,100
|
1,62,000
|
1,31,700
|
Announcement Date
|
30/10/19
|
26/10/20
|
28/04/21
|
25/10/22
|
30/10/23
|
26/04/24
|
Fiscal Period: Gennaio |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net sales
1 |
4,016
|
4,046
|
4,116
|
4,742
|
5,070
|
4,877
|
EBITDA
1 |
3,278
|
3,060
|
3,086
|
3,648
|
3,853
|
3,649
|
EBIT
1 |
2,380
|
2,144
|
2,136
|
2,532
|
2,722
|
2,523
|
Operating Margin
|
59.26%
|
52.99%
|
51.9%
|
53.4%
|
53.68%
|
51.72%
|
Earnings before Tax (EBT)
1 |
2,092
|
1,834
|
1,820
|
2,200
|
2,347
|
2,119
|
Net income
1 |
2,092
|
1,834
|
1,820
|
2,200
|
2,346
|
2,117
|
Net margin
|
52.09%
|
45.33%
|
44.22%
|
46.39%
|
46.28%
|
43.42%
|
EPS
2 |
6,744
|
5,897
|
5,852
|
6,126
|
6,527
|
5,890
|
Free Cash Flow
1 |
-44,925
|
-951
|
1,649
|
-22,426
|
2,729
|
2,427
|
FCF margin
|
-1,118.66%
|
-23.5%
|
40.06%
|
-472.92%
|
53.82%
|
49.76%
|
FCF Conversion (EBITDA)
|
-
|
-
|
53.43%
|
-
|
70.82%
|
66.51%
|
FCF Conversion (Net income)
|
-
|
-
|
90.59%
|
-
|
116.29%
|
114.62%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
6,924
|
6,517
|
Announcement Date
|
30/10/19
|
26/10/20
|
28/04/21
|
25/10/22
|
30/10/23
|
26/04/24
|
Fiscal Period: January |
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 S1
|
2024 S2
|
2025 S1
|
2025 S2
|
---|
Net sales
1 |
2,013
|
2,023
|
2,058
|
2,073
|
2,080
|
2,371
|
2,632
|
2,439
|
2,438
|
2,520
|
2,520
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
1,103
|
1,072
|
1,067
|
1,078
|
1,072
|
1,266
|
1,454
|
1,268
|
1,254
|
1,292
|
1,277
|
Operating Margin
|
54.79%
|
52.99%
|
51.85%
|
52%
|
51.54%
|
53.37%
|
55.23%
|
52.01%
|
51.43%
|
51.27%
|
50.67%
|
Earnings before Tax (EBT)
|
-
|
918
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
943
|
917
|
910
|
921
|
913
|
1,100
|
1,278
|
1,068
|
1,049
|
1,046
|
1,026
|
Net margin
|
46.85%
|
45.33%
|
44.22%
|
44.43%
|
43.89%
|
46.4%
|
48.57%
|
43.8%
|
43.04%
|
41.51%
|
40.71%
|
EPS
2 |
3,034
|
2,951
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
2,909
|
2,853
|
Dividend per Share
2 |
3,320
|
3,240
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
3,235
|
3,182
|
Announcement Date
|
17/03/20
|
26/10/20
|
16/03/21
|
15/11/21
|
18/03/22
|
25/10/22
|
17/03/23
|
15/09/23
|
19/03/24
|
-
|
-
|
Fiscal Period: January |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net Debt
1 |
30,553
|
31,526
|
31,358
|
37,339
|
37,537
|
37,285
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
9.321
x
|
10.3
x
|
10.16
x
|
10.24
x
|
9.743
x
|
10.22
x
|
Free Cash Flow
1 |
-44,925
|
-951
|
1,649
|
-22,426
|
2,729
|
2,427
|
ROE (net income / shareholders' equity)
|
7.78%
|
5.51%
|
5.5%
|
6.13%
|
6.06%
|
5.46%
|
ROA (Net income/ Total Assets)
|
2.69%
|
1.95%
|
1.95%
|
2.12%
|
2.11%
|
1.95%
|
Assets
1 |
77,888
|
93,878
|
93,386
|
1,03,739
|
1,11,134
|
1,08,759
|
Book Value Per Share
2 |
1,07,762
|
1,06,472
|
1,06,112
|
1,08,038
|
1,07,421
|
1,07,196
|
Cash Flow per Share
2 |
6,116
|
5,222
|
5,762
|
3,650
|
4,487
|
5,189
|
Capex
1 |
47,008
|
3,250
|
422
|
24,738
|
184
|
-
|
Capex / Sales
|
1,170.52%
|
80.33%
|
10.25%
|
521.68%
|
3.63%
|
-
|
Announcement Date
|
30/10/19
|
26/10/20
|
28/04/21
|
25/10/22
|
30/10/23
|
26/04/24
|
|
1st Jan change
|
Capi.
|
---|
| -5.87% | 303M | | +9.60% | 59.09B | | -1.26% | 13.76B | | +0.10% | 7.58B | | -10.80% | 5.82B | | +10.32% | 3.51B | | +1.82% | 3.36B | | -1.26% | 3.22B | | -2.65% | 2.87B | | +16.92% | 2.84B |
Healthcare REITs
|